C. Knight–Gibson

发表

Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 1998, Journal of the American Society of Nephrology : JASN.

A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age.

E. Garrett, J. Otvos, Lin Zhang, 2005, JAMA.

Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.

O. Samuelsson, P. Attman, P. Alaupovic, 2002, Kidney international.

Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 2006, Kidney international.

Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.

R. Norum, P. Alaupovic, C. Knight-Gibson, 1992, Biochimica et biophysica acta.

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.

H. Wedel, H. Mulec, O. Samuelsson, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.

W. Mack, H. Hodis, P. Alaupovic, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients

O. Samuelsson, A. Johansson, P. Attman, 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.

O. Samuelsson, A. Johansson, P. Attman, 1999, Kidney international.

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

L. Labree, W. Mack, D. Kramsch, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Apolipoprotein C-I Induces Apoptosis in Human Aortic Smooth Muscle Cells via Recruiting Neutral Sphingomyelinase

P. Alaupovic, P. Kwiterovich, D. Virgil, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.

R. Gregg, H. Brewer, C. S. Wang, 1991, Journal of lipid research.

Apolipoprotein‐B subclasses as acceptors of cholesteryl esters transferred by CETP

J. Bagdade, P. Alaupovic, D. M. Lee, 2008, European journal of clinical investigation.

CETP‐mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes

J. Bagdade, R. Gerkin, P. Alaupovic, 2012, European journal of clinical investigation.

Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.

R. Norum, P. Alaupovic, C. Knight-Gibson, 1991, Journal of lipid research.

Apolipoprotein C-III, Hypertriglyceridemia and Triglyceride-Rich Lipoproteins in Uremia

O. Samuelsson, A. Johansson, P. Attman, 1999, Mineral and Electrolyte Metabolism.

The compositional abnormalities of lipoproteins in diabetic renal failure.

O. Samuelsson, P. Attman, P. Alaupovic, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency.

O. Samuelsson, P. Attman, M. Aurell, 1993, Nephron.

Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.

P. Alaupovic, E. Koren, N. Dashti, 1987, Biochemistry.

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

L. Labree, P. Alaupovic, L. Cashin-Hemphill, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Distribution of immunochemically defined apoB-containing lipoprotein subclasses in T1D.

J. Bagdade, C. Knight-Gibson, Diana M. Lee, 2009, Diabetes research and clinical practice.

Dyslipidemia in Peritoneal Dialysis — Relation to Dialytic Variables

O. Samuelsson, A. Johansson, B. Haraldsson, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression

H. Mulec, O. Samuelsson, P. Attman, 1999, Nephron.

Composition of Plasma ApoA-I-Containing Lipoprotein Particles in Children and Adults

P. Blackett, P. Alaupovic, C. Knight-Gibson, 1991, Pediatric Research.

Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. II. Isolation of apolipoprotein B-containing lipoproteins from human plasma.

P. Alaupovic, E. Koren, L. DeBault, 1986, Biochimica et biophysica acta.

Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.

G. Franceschini, C. Sirtori, P. Alaupovic, 1993, Journal of lipid research.

Separation of ApoA- and ApoB-containing lipoproteins of human plasma by affinity chromatography on concanavalin A.

G. Schinella, H. Tournier, P. Alaupovic, 1991, Progress in lipid research.

The lipoprotein A-II (LP-A-II) family in normolipidemic subjects and patients with ApoA-I deficiency.

P. Alaupovic, C. Knight-Gibson, M. Ayrault-Jarrier, 1991, Progress in lipid research.

Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.

P. Alaupovic, D. M. Lane, L. Laughlin, 1995, The American journal of cardiology.

Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.

P. Attman, P. Alaupovic, M. Tavella, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.

H. Mulec, O. Samuelsson, P. Attman, 1997, Nephron.

A prominent large high-density lipoprotein at birth enriched in apolipoprotein C-I identifies a new group of infancts of lower birth weight and younger gestational age

E. Garrett, J. Otvos, S. Cockrill, 2003 .